|
|
Taiwan Academic Institutional Repository >
Browse by Author
|
"jia horng kao"
Showing items 961-1010 of 1180 (24 Page(s) Totally)
<< < 15 16 17 18 19 20 21 22 23 24 > >>
View [10|25|50] records per page
| 臺大學術典藏 |
2018-09-10T08:04:05Z |
Pegylated interferon alfa-2a monotherapy for hemodialysis patients with acute hepatitis C.
|
Chun-Jen Liu;Pei-Jer Chen;Hung-Bin Tsai;Chen-Hua Liu;Ding-Shinn Chen;Jia-Horng Kao; CHUN-JEN LIU; PEI-JER CHEN; HUNG-BIN TSAI; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:04:05Z |
Pegylated interferon alfa-2a monotherapy for hemodialysis patients with acute hepatitis C.
|
Chun-Jen Liu;Pei-Jer Chen;Hung-Bin Tsai;Chen-Hua Liu;Ding-Shinn Chen;Jia-Horng Kao; CHUN-JEN LIU; PEI-JER CHEN; HUNG-BIN TSAI; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:39:51Z |
GB virus-C/hepatitis G virus infection in Taiwan: A virus that fails to cause a disease?
|
Kao, J.-H.;Chen, D.-S.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:39:51Z |
Molecular methods of measurement of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection: Implications for occupational health practice
|
Kao, J.-H.;Heptonstall, J.;Chen, D.-S.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:39:51Z |
Prevalence and implication of TT virus infection: Minimal role in patients with non-A-E hepatitis in Taiwan
|
Kao, J.-H.;Chen, W.;Hsiang, S.-C.;Chen, P.-J.;Lai, M.-Y.;Chen, D.-S.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:39:50Z |
IL-10 promoter gene polymorphisms and sustained response to combination therapy in Taiwanese chronic hepatitis C patients
|
Chuang, J.Y.; Yang, S.S.; Lu, Y.T.; Hsieh, Y.Y.; Chen, C.Y.; Chang, S.C.; Chang, C.S.; Yeh, H.Z.; Kao, J.H.; JIA-HORNG KAO; Chuang, J.Y.; Yang, S.S.; Lu, Y.T.; Hsieh, Y.Y.; Chen, C.Y.; Chang, S.C.; Chang, C.S.; Yeh, H.Z.; Kao, J.H. |
| 臺大學術典藏 |
2018-09-10T07:39:50Z |
Peginterferon alfa-2b or alfa-2a with ribavirin for hepatitis C
|
Hsu, C.-S.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:39:50Z |
Prevention of hepatocellular carcinoma in hepatitis B virus infection
|
Lim, S.G.;Mohammed, R.;Yuen, M.-F.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:39:49Z |
Elevation of serum aminotransferase activity increases risk of carotid atherosclerosis in patients with non-alcoholic fatty liver disease
|
Wang, Chia-Chi;Lin, Shinn-Kuang;Tseng, Yuan-Fu;Hsu, Ching-Sheng;Tseng, Tai-Chung;Lin, Hans Hsien-Hong;Wang, Li-Yu;Kao, Jia-Horng; JIA-HORNG KAO; WANG, CHIA-CHI; LIN, SHINN-KUANG; TSENG, YUAN-FU; HSU, CHING-SHENG; TSENG, TAI-CHUNG; LIN, HANS HSIEN-HONG; WANG, LI-YU; KAO, JIA-HORNG |
| 臺大學術典藏 |
2018-09-10T07:39:49Z |
Esomeprazole for asthma [7]
|
Hsu, Ching-Sheng;Kao, Jia-Horng; JIA-HORNG KAO; HSU, CHING-SHENG; KAO, JIA-HORNG |
| 臺大學術典藏 |
2018-09-10T07:39:49Z |
Factors affecting early viral load decline of Asian chronic hepatitis C patients receiving pegylated interferon plus ribavirin therapy
|
Hsu, C.-S.;Liu, C.-H.;Liu, C.-J.;Chen, C.-L.;Lai, M.-Y.;Chen, P.-J.;Chen, D.-S.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:39:49Z |
Factors associated with progression to hepatocellular carcinoma and to death from liver complications in patients with HBsAg-positive cirrhosis
|
Tong, Myron John; Hsien, Carlos; Song, Joanna Jungeun; Kao, Jia Horng; Sun, Hai-En; Hsu, Leeyen; Han, Steven-Huy; Durazo, Francisco Antonio; Saab, Sammy; Blatt, Lawrence Mitchell; JIA-HORNG KAO; Tong, Myron John; Hsien, Carlos; Song, Joanna Jungeun; Kao, Jia Horng; Sun, Hai-En; Hsu, Leeyen; Han, Steven-Huy; Durazo, Francisco Antonio; Saab, Sammy; Blatt, Lawrence Mitchell |
| 臺大學術典藏 |
2018-09-10T07:39:49Z |
HBV genotypes and chronicification of acute hepatitis B: More questions than answers
|
Lin, C.-L.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:39:49Z |
HBsAg Seroclearance: The More and Earlier, the Better
|
Tseng, Tai-Chung;Kao, Jia-Horng; JIA-HORNG KAO; TSENG, TAI-CHUNG; KAO, JIA-HORNG |
| 臺大學術典藏 |
2018-09-10T07:39:48Z |
Reactivation of hepatitis B virus in an inactive hepatitis B carrier with glucocorticoid pulse therapy
|
Tseng, Tai-Chung;Liu, Chun-Jen;Hsieh, San-Chia;Chen, Pei-Jer;Lai, Ming-Yang;Chen, Ding-Shinn;Kao, Jia-Horng; CHUN-JEN LIU; DING-SHINN CHEN; JIA-HORNG KAO; TSENG, TAI-CHUNG; LIU, CHUN-JEN; HSIEH, SAN-CHIA; CHEN, PEI-JER; LAI, MING-YANG; CHEN, DING-SHINN; KAO, JIA-HORNG |
| 臺大學術典藏 |
2018-09-10T07:39:48Z |
Association of baseline viral factors with response to lamivudine therapy in chronic hepatitis B patients with high serum alanine aminotransferase levels
|
Tseng, T.-C.;Liu, C.-J.;Wang, C.-C.;Chen, P.-J.;Lai, M.-Y.;Chen, D.-S.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:39:48Z |
Both insulin resistance and alanine aminotransferase level increase the risks of cardiovascular disease in fatty liver disease
|
Hsu, Ching-Sheng;Chen, Ding-Shinn;Kao, Jia-Horng; DING-SHINN CHEN; JIA-HORNG KAO; HSU, CHING-SHENG; CHEN, DING-SHINN; KAO, JIA-HORNG |
| 臺大學術典藏 |
2018-09-10T07:39:48Z |
Capsule endoscopy versus colonoscopy
|
Hsu, C.-S.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:39:34Z |
Liver and peripheral blood mononuclear cells are not major sites for GB virus-C/hepatitis G virus replication
|
Kao, J.-H.; Chen, W.; Chen, P.-J.; Lai, M.-Y.; Chen, D.-S.; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:39:34Z |
Minimal role of GB virus-C/hepatitis G virus in fulminant and subfulminant hepatitis in Taiwan
|
Liu, C.-J.; Kao, J.-H.; Lai, M.-Y.; Chen, P.-J.; Chu, J.-S.; Chen, W.; Chen, D.-S.; CHUN-JEN LIU; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:39:33Z |
Comparison of two methods for quantification of hepatitis B viral DNA
|
Kao, J.-H.; Wood, M.; Chen, P.-J.; Lai, M.-Y.; Chen, D.-S.; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:37:25Z |
Peginterferon Alfa-2a Plus Ribavirin for the Treatment of Dual Chronic Infection With Hepatitis B and C Viruses
|
Liu, Chun-Jen;Chuang, Wan-Long;Lee, Chuan-Mo;Yu, Ming-Lung;Lu, Sheng-Nan;Wu, Shun-Sheng;Chen, Chi-Ling;Yang, Sien-Sing;Kao, Jia-Horng;Liu, Chen-Hua;Su, Wei-Wen;Jeng, Yung-Ming;Chen, Pei-Jer;Chen, Ding-Shinn; CHUN-JEN LIU; YUNG-MING JENG; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO; LIU, CHUN-JEN; CHUANG, WAN-LONG; LEE, CHUAN-MO; YU, MING-LUNG; LU, SHENG-NAN; WU, SHUN-SHENG; CHEN, CHI-LING; YANG, SIEN-SING; KAO, JIA-HORNG; LIU, CHEN-HUA; SU, WEI-WEN; JENG, YUNG-MING; CHEN, PEI-JER; CHEN, DING-SHINN |
| 臺大學術典藏 |
2018-09-10T07:35:35Z |
Association of lipid profiles with hepatitis C viral load in chronic hepatitis C patients with genotype 1 or 2 infection
|
Hsu, C.-S.;Liu, C.-H.;Liu, C.-J.;Wang, C.-C.;Chen, C.-L.;Lai, M.-Y.;Chen, P.-J.;Chen, D.-S.;Kao, J.-H.; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:35:34Z |
Hepatitis B virus basal core promoter mutation and DNA load correlate with expression of hepatitis B core antigen in patients with chronic hepatitis B
|
Liu, Chun-Jen;Jeng, Yung-Ming;Chen, Chi-Ling;Chen, Pei-Jer;Chen, Ting-Chi;Liu, Chen-Hua;Lai, Ming-Yang;Chen, Ding-Shinn;Kao, Jia-Horng; CHUN-JEN LIU; PEI-JER CHEN; YUNG-MING JENG; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO; LIU, CHUN-JEN; JENG, YUNG-MING; CHEN, CHI-LING; CHEN, PEI-JER; CHEN, TING-CHI; LIU, CHEN-HUA; LAI, MING-YANG; CHEN, DING-SHINN; KAO, JIA-HORNG |
| 臺大學術典藏 |
2018-09-10T07:35:33Z |
Human leukocyte antigen-DRB1*1101 correlates with less severe hepatitis in Taiwanese male carriers of hepatitis B virus
|
PEI-JER CHEN; CHUNG-YI HU; DING-SHINN CHEN; JIA-HORNG KAO; HUANG, YI-WEN; HU, CHUNG-YI; CHEN, CHI-LING; LIAO, YA-TANG; LIU, CHUN-JEN; LAI, MING-YANG; CHEN, PEI-JER; YANG, SIEN-SING; HU, JUI-TING; CHEN, DING-SHINN; KAO, JIA-HORNG; CHUN-JEN LIU; Huang, Yi-Wen;Hu, Chung-Yi;Chen, Chi-Ling;Liao, Ya-Tang;Liu, Chun-Jen;Lai, Ming-Yang;Chen, Pei-Jer;Yang, Sien-Sing;Hu, Jui-Ting;Chen, Ding-Shinn;Kao, Jia-Horng; YI-WEN HUANG |
| 臺大學術典藏 |
2018-09-10T07:35:33Z |
High serum adiponectin correlates with advanced liver disease in patients with chronic hepatitis B virus infection
|
Liu, Chun-Jen;Chen, Pei-Jer;Lai, Ming-Yang;Liu, Chen-Hua;Chen, Chi-Ling;Kao, Jia-Horng;Chen, Ding-Shinn; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO; LIU, CHUN-JEN; CHEN, PEI-JER; LAI, MING-YANG; LIU, CHEN-HUA; CHEN, CHI-LING; KAO, JIA-HORNG; CHEN, DING-SHINN |
| 臺大學術典藏 |
2018-09-10T07:35:33Z |
Hepatitis B virus genotype B has an earlier emergence of lamivudine resistance than genotype C
|
Hsieh, T.-H.;Tseng, T.-C.;Liu, C.-J.;Lai, M.-Y.;Chen, P.-J.;Hsieh, H.-L.;Chen, D.-S.;Kao, J.-H.; CHUN-JEN LIU; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:35:31Z |
Pegylated interferon α-2a plus low-dose ribavirin for the retreatment of dialysis chronic hepatitis C patients who relapsed from prior interferon monotherapy
|
Liu, C.-H.;Liang, C.-C.;Liu, C.-J.;Tsai, H.-B.;Hung, P.-H.;Hsu, S.-J.;Chen, S.-L.;Lin, J.-W.;Lai, M.-Y.;Chen, J.-H.;Chen, P.-J.;Chen, D.-S.;Kao, J.-H.; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:23:47Z |
Uridine diphosphate glucuronosyl transferase 1A1 promoter polymorphism is associated with choledocholithiasis in Taiwanese patients
|
Chu, Cheng-Hsin;Yang, An-Ming;Kao, Jia- Horng;Liu, Chia-Yuan;Chang, Wen-Hsiung;Yang, Wei-Shiung; WEI-SHIUNG YANG; JIA-HORNG KAO; CHU, CHENG-HSIN; YANG, AN-MING; KAO, JIA- HORNG; LIU, CHIA-YUAN; CHANG, WEN-HSIUNG; YANG, WEI-SHIUNG |
| 臺大學術典藏 |
2018-09-10T07:06:33Z |
Hepatitis C virus infection in Taiwan
|
Kao, J.-H.;Chen, D.-S.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:06:31Z |
Erratum: Asian-Pacific consensus statement on the management of chronic hepatitis B: A 2008 update (Hepatology International 10.1007/s12072-008-9080-3)
|
Liaw, Y.-F.;Leung, N.;Kao, J.-H.;Teerha, P.;Gane, E.;Han, K.-H.;Guan, R.;Lau, G.K.K.;Locarnini, S.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:06:31Z |
Genetic variability of hepatitis B virus and response to antiviral therapy
|
Liu, C.-J.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:06:31Z |
Hepatitis B viral factors and clinical outcomes of chronic hepatitis B
|
Lin, C.-L.;Kao, J.-H.; Lin, CL; JIA-HORNG KAO; Kao, JH. |
| 臺大學術典藏 |
2018-09-10T07:06:31Z |
Hepatitis B viral genotype in Taiwanese patients with acute hepatitis B
|
Huang, Y.-W.;Lin, C.-L.;Chen, P.-J.;Lai, M.-Y.;Kao, J.-H.;Chen, D.-S.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:06:31Z |
Insulin resistance, adipocytokines, and hepatitis C virus infection: A missing link?
|
Hsu, C.-S.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:06:30Z |
Combination of Hepatitis B Viral Factors and Advanced Liver Disease in HBeAg-Negative Patients: The More, the Worse?
|
Lin, Chih–Lin; Branch, Ren–Ai; Kao, Jia–Horng; JIA-HORNG KAO; Lin, Chih–Lin; Branch, Ren–Ai; Kao, Jia–Horng |
| 臺大學術典藏 |
2018-09-10T07:06:30Z |
Core promoter mutations of hepatitis B virus and hepatocellular carcinoma: Story beyond A1762T/G1764A mutations
|
Liu, C.-J.;Kao, J.-H.; CHUN-JEN LIU; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:06:30Z |
Diagnosis of hepatitis B virus infection through serological and virological markers
|
Kao, J.-H.; JIA-HORNG KAO; Kao, JH |
| 臺大學術典藏 |
2018-09-10T07:06:29Z |
Asian-Pacific consensus statement on the management of chronic hepatitis B: A 2008 update
|
Liaw, Yun-Fan; Leung, Nancy; Kao, Jia-Horng; Piratvisuth, Teerha; Gane, Edward; Han, Kwang-Hyub; Guan, Richard; Lau, George K. K.; Locarnini, Stephen; JIA-HORNG KAO; Liaw, Yun-Fan; Leung, Nancy; Kao, Jia-Horng; Piratvisuth, Teerha; Gane, Edward; Han, Kwang-Hyub; Guan, Richard; Lau, George K. K.; Locarnini, Stephen |
| 臺大學術典藏 |
2018-09-10T07:06:29Z |
Association of Insulin Resistance with Alanine Aminotransferase Activity in Patients with Nonalcoholic Fatty Liver Disease
|
Wang, C.-C.;Wu, W.-W.;Hsu, C.-S.;Wang, P.-C.;Lin, H.H.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:06:27Z |
Association of chronic hepatitis B virus infection with insulin resistance and hepatic steatosis
|
Wang, C.-C.;Hsu, C.-S.;Liu, C.-J.;Kao, J.-H.;Chen, D.-S.; Wang, CC; CHUN-JEN LIU; DING-SHINN CHEN; Hsu, CS; Liu, CJ; JIA-HORNG KAO; Kao, JH; Chen, DS. |
| 臺大學術典藏 |
2018-09-10T07:06:12Z |
Universal Hepatitis B Vaccination: Killing 2 Birds with 1 Stone
|
Kao, J.-H.; Chen, D.-S.; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:06:12Z |
Brief communication: Efficacy of ribavirin plus interferon α on viraemia of GB virus-C/hepatitis G virus: Comparison with interferon α alone
|
Kao, J.-H.; Lai, M.-Y.; Chen, W.; Chen, P.-J.; Chen, D.-S.; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:06:12Z |
Effects of GB virus-C/hepatitis G virus on hepatitis B and C viremia in multiple hepatitis virus infections
|
Kao, J.-H.; Chen, R.-J.; Lai, M.-Y.; Chen, W.; Chen, D.-S.; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:06:11Z |
Metabolic profiles in patients with chronic hepatitis C: A case-control study
|
Hsu, C.-S.; Liu, C.-J.; Liu, C.-H.; Chen, C.-L.; Lai, M.-Y.; Chen, P.-J.; Chen, D.-S.; Kao, J.-H.; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:06:10Z |
Critical analysis of the immune tolerance phase of chronic HBV infection: Natural history and diagnosis
|
Kao, J.-H.; Chen, D.-S.; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:06:09Z |
A higher alanine aminotransferase level correlates with earlier hepatitis B e antigen seroconversion in lamivudine-treated chronic hepatitis B patients
|
Tseng, T.-C.; Liu, C.-J.; Wang, C.-C.; Chen, P.-J.; Lai, M.-Y.; Kao, J.-H.; Chen, D.-S.; CHUN-JEN LIU; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:02:33Z |
High hepatitis C viral load is associated with insulin resistance in patients with chronic hepatitis C
|
Hsu, C.-S.;Liu, C.-J.;Liu, C.-H.;Wang, C.-C.;Chen, C.-L.;Lai, M.-Y.;Chen, P.-J.;Kao, J.-H.;Chen, D.-S.; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:02:32Z |
Pegylated interferon-α-2a plus ribavirin for treatment-naive Asian patients with hepatitis C virus genotype 1 infection: A multicenter, randomized controlled trial
|
Liu, C.-H.;Liu, C.-J.;Lin, C.-.;Liang, C.-C.;Hsu, S.-J.;Yang, S.-S.;Hsu, C.-S.;Tseng, T.-C.;Wang, C.-C.;Lai, M.-Y.;Chen, J.-H.;Chen, P.-J.;Chen, D.-S.;Kao, J.-H.; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:02:32Z |
Pegylated interferon α-2a versus standard interferon α-2a for treatment-naïve dialysis patients with chronic hepatitis C: A randomised study
|
Liu, C.-H.;Liang, C.-C.;Lin, J.-W.;Chen, S.-I.;Tsai, H.-B.;Chang, C.-S.;Hung, P.-H.;Kao, J.-H.;Liu, C.-J.;Lai, M.-Y.;Chen, J.-H.;Chen, P.-J.;Kao, J.-H.;Chen, D.-S.; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
Showing items 961-1010 of 1180 (24 Page(s) Totally)
<< < 15 16 17 18 19 20 21 22 23 24 > >>
View [10|25|50] records per page
|
